TrialInfluenza and other respiratory viruses2024

A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF-Based Regimen in Japanese Adults Aged 60 Years and Older.

Takashi Eto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.